US Stock MarketDetailed Quotes

VVOS Vivos Therapeutics

Watchlist
  • 2.4800
  • +0.0300+1.22%
Trading Jun 10 13:25 ET
8.00MMarket Cap-224P/E (TTM)

Vivos Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
-11.36%3.42M
-13.87%13.8M
-17.77%3.25M
-22.26%3.3M
-18.86%3.4M
5.85%3.86M
-5.10%16.02M
-10.10%3.95M
-6.60%4.25M
-6.96%4.18M
Operating revenue
-11.36%3.42M
-13.87%13.8M
-17.77%3.25M
-22.26%3.3M
-18.86%3.4M
5.85%3.86M
-5.10%16.02M
-10.10%3.95M
-6.60%4.25M
-6.96%4.18M
Cost of revenue
-2.50%1.48M
-7.91%5.53M
-16.35%1.31M
-19.83%1.4M
-18.73%1.3M
39.07%1.52M
40.27%6.01M
21.68%1.57M
28.39%1.75M
82.82%1.6M
Gross profit
-17.12%1.94M
-17.45%8.27M
-18.71%1.94M
-23.96%1.9M
-18.93%2.1M
-8.39%2.34M
-20.51%10.02M
-23.27%2.38M
-21.58%2.5M
-28.59%2.59M
Operating expense
-22.06%5.72M
-27.06%25.57M
-26.34%6.22M
-31.84%5.39M
-30.75%6.62M
-20.11%7.34M
9.28%35.05M
-12.07%8.45M
-9.01%7.9M
24.29%9.55M
Selling and administrative expenses
-22.20%5.58M
-27.44%24.95M
-26.64%6.07M
-32.23%5.24M
-31.13%6.47M
-20.61%7.17M
9.70%34.38M
-12.30%8.28M
-9.01%7.73M
25.37%9.39M
-Selling and marketing expense
3.97%655K
-53.80%2.47M
-55.28%606K
-42.04%641K
-65.27%590K
-16.33%630K
-3.80%5.34M
2.89%1.36M
-44.03%1.11M
21.53%1.7M
-General and administrative expense
-24.72%4.92M
-22.60%22.48M
-21.03%5.47M
-30.59%4.6M
-23.59%5.88M
-21.00%6.54M
12.60%29.04M
-14.76%6.92M
1.61%6.62M
26.25%7.69M
Depreciation amortization depletion
-16.57%146K
-7.17%621K
-11.83%149K
-14.29%150K
-8.64%148K
8.02%175K
-8.73%669K
0.60%169K
-9.33%175K
-16.92%162K
-Depreciation and amortization
-16.57%146K
-7.17%621K
-11.83%149K
-14.29%150K
-8.64%148K
8.02%175K
-8.73%669K
0.60%169K
-9.33%175K
-16.92%162K
Operating profit
24.38%-3.79M
30.90%-17.3M
29.34%-4.28M
35.47%-3.49M
35.14%-4.52M
24.61%-5.01M
-28.56%-25.03M
6.72%-6.06M
1.74%-5.41M
-71.48%-6.96M
Net non-operating interest income expense
Other net income (expense)
-99.33%22K
213.07%3.71M
196.15%25K
5,270.37%1.4M
-3,510.71%-1.01M
152.45%3.3M
247.70%1.19M
97.04%-26K
-154.00%-27K
-255.56%-28K
Gain on sale of security
----
--3.78M
---131K
--1.6M
---867K
--3.18M
----
----
----
----
Special income (charges)
----
--0
586.36%151K
---151K
--0
----
241.27%1.29M
102.41%22K
--0
--0
-Less:Other special charges
----
----
----
----
----
----
---1.29M
---22K
----
----
-Write off
----
----
----
--151K
----
----
----
----
--0
----
Other non- operating income (expenses)
-82.68%22K
35.64%-65K
110.42%5K
-96.30%-53K
-414.29%-144K
504.76%127K
-193.52%-101K
-250.00%-48K
-154.00%-27K
-255.56%-28K
Income before tax
-120.96%-3.76M
43.04%-13.58M
30.05%-4.26M
61.48%-2.09M
20.94%-5.53M
68.05%-1.7M
-17.53%-23.85M
17.64%-6.09M
0.35%-5.43M
-72.94%-6.99M
Income tax
Net income
-120.96%-3.76M
43.04%-13.58M
30.05%-4.26M
61.48%-2.09M
20.94%-5.53M
68.05%-1.7M
-17.53%-23.85M
17.64%-6.09M
0.35%-5.43M
-72.94%-6.99M
Net income continuous Operations
-120.96%-3.76M
43.04%-13.58M
30.05%-4.26M
61.48%-2.09M
20.94%-5.53M
68.05%-1.7M
-17.53%-23.85M
17.64%-6.09M
0.35%-5.43M
-72.94%-6.99M
Minority interest income
Net income attributable to the parent company
-120.96%-3.76M
43.04%-13.58M
30.05%-4.26M
61.48%-2.09M
20.94%-5.53M
68.05%-1.7M
-17.53%-23.85M
17.64%-6.09M
0.35%-5.43M
-72.94%-6.99M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-120.96%-3.76M
43.04%-13.58M
30.05%-4.26M
61.48%-2.09M
20.94%-5.53M
68.05%-1.7M
-17.53%-23.85M
17.64%-6.09M
0.35%-5.43M
-72.94%-6.99M
Basic earnings per share
5.23%-1.63
56.99%-11.14
39.00%-3.05
72.66%-1.75
45.45%-4.5
72.48%-1.72
-7.92%-25.9
41.18%-5
1.54%-6.4
-73.68%-8.25
Diluted earnings per share
5.23%-1.63
56.99%-11.14
39.00%-3.05
72.66%-1.75
45.45%-4.5
72.48%-1.72
-7.92%-25.9
41.18%-5
1.54%-6.4
-73.68%-8.25
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue -11.36%3.42M-13.87%13.8M-17.77%3.25M-22.26%3.3M-18.86%3.4M5.85%3.86M-5.10%16.02M-10.10%3.95M-6.60%4.25M-6.96%4.18M
Operating revenue -11.36%3.42M-13.87%13.8M-17.77%3.25M-22.26%3.3M-18.86%3.4M5.85%3.86M-5.10%16.02M-10.10%3.95M-6.60%4.25M-6.96%4.18M
Cost of revenue -2.50%1.48M-7.91%5.53M-16.35%1.31M-19.83%1.4M-18.73%1.3M39.07%1.52M40.27%6.01M21.68%1.57M28.39%1.75M82.82%1.6M
Gross profit -17.12%1.94M-17.45%8.27M-18.71%1.94M-23.96%1.9M-18.93%2.1M-8.39%2.34M-20.51%10.02M-23.27%2.38M-21.58%2.5M-28.59%2.59M
Operating expense -22.06%5.72M-27.06%25.57M-26.34%6.22M-31.84%5.39M-30.75%6.62M-20.11%7.34M9.28%35.05M-12.07%8.45M-9.01%7.9M24.29%9.55M
Selling and administrative expenses -22.20%5.58M-27.44%24.95M-26.64%6.07M-32.23%5.24M-31.13%6.47M-20.61%7.17M9.70%34.38M-12.30%8.28M-9.01%7.73M25.37%9.39M
-Selling and marketing expense 3.97%655K-53.80%2.47M-55.28%606K-42.04%641K-65.27%590K-16.33%630K-3.80%5.34M2.89%1.36M-44.03%1.11M21.53%1.7M
-General and administrative expense -24.72%4.92M-22.60%22.48M-21.03%5.47M-30.59%4.6M-23.59%5.88M-21.00%6.54M12.60%29.04M-14.76%6.92M1.61%6.62M26.25%7.69M
Depreciation amortization depletion -16.57%146K-7.17%621K-11.83%149K-14.29%150K-8.64%148K8.02%175K-8.73%669K0.60%169K-9.33%175K-16.92%162K
-Depreciation and amortization -16.57%146K-7.17%621K-11.83%149K-14.29%150K-8.64%148K8.02%175K-8.73%669K0.60%169K-9.33%175K-16.92%162K
Operating profit 24.38%-3.79M30.90%-17.3M29.34%-4.28M35.47%-3.49M35.14%-4.52M24.61%-5.01M-28.56%-25.03M6.72%-6.06M1.74%-5.41M-71.48%-6.96M
Net non-operating interest income expense
Other net income (expense) -99.33%22K213.07%3.71M196.15%25K5,270.37%1.4M-3,510.71%-1.01M152.45%3.3M247.70%1.19M97.04%-26K-154.00%-27K-255.56%-28K
Gain on sale of security ------3.78M---131K--1.6M---867K--3.18M----------------
Special income (charges) ------0586.36%151K---151K--0----241.27%1.29M102.41%22K--0--0
-Less:Other special charges ---------------------------1.29M---22K--------
-Write off --------------151K------------------0----
Other non- operating income (expenses) -82.68%22K35.64%-65K110.42%5K-96.30%-53K-414.29%-144K504.76%127K-193.52%-101K-250.00%-48K-154.00%-27K-255.56%-28K
Income before tax -120.96%-3.76M43.04%-13.58M30.05%-4.26M61.48%-2.09M20.94%-5.53M68.05%-1.7M-17.53%-23.85M17.64%-6.09M0.35%-5.43M-72.94%-6.99M
Income tax
Net income -120.96%-3.76M43.04%-13.58M30.05%-4.26M61.48%-2.09M20.94%-5.53M68.05%-1.7M-17.53%-23.85M17.64%-6.09M0.35%-5.43M-72.94%-6.99M
Net income continuous Operations -120.96%-3.76M43.04%-13.58M30.05%-4.26M61.48%-2.09M20.94%-5.53M68.05%-1.7M-17.53%-23.85M17.64%-6.09M0.35%-5.43M-72.94%-6.99M
Minority interest income
Net income attributable to the parent company -120.96%-3.76M43.04%-13.58M30.05%-4.26M61.48%-2.09M20.94%-5.53M68.05%-1.7M-17.53%-23.85M17.64%-6.09M0.35%-5.43M-72.94%-6.99M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -120.96%-3.76M43.04%-13.58M30.05%-4.26M61.48%-2.09M20.94%-5.53M68.05%-1.7M-17.53%-23.85M17.64%-6.09M0.35%-5.43M-72.94%-6.99M
Basic earnings per share 5.23%-1.6356.99%-11.1439.00%-3.0572.66%-1.7545.45%-4.572.48%-1.72-7.92%-25.941.18%-51.54%-6.4-73.68%-8.25
Diluted earnings per share 5.23%-1.6356.99%-11.1439.00%-3.0572.66%-1.7545.45%-4.572.48%-1.72-7.92%-25.941.18%-51.54%-6.4-73.68%-8.25
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg